Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Lion's Mane
Selected research topic
Immune and respiratory health
The comparison is unconfirmed, so the findings cannot establish this ingredient’s effect.
Some publications still need interpretation checks and are kept separate from the findings below.
- Publications for this topic
- 4
- Human comparison publications
- 0
- Publications needing review
- 3
Findings in the studies
anti-inflammatory
Research with unclear study subject or type
- A change was reported, but the comparison could not be confirmed.General population
Measurement and study conditions
- Review
- Review
- Unknown intervention
- General population
- Mechanistic outcome
- Study subject not identified
- Timepoint: unspecified
- Study comparison: not_confirmed
This result is held for interpretation. That does not mean research found no effect.
Outcome groups needing additional review (3)
- expression of inflammatory cytokines IL-6, TNF-α and IL-1β · Distinct papers needing additional review: 1Direction unclear: 1
- proliferation of lymphocytes · Distinct papers needing additional review: 1Direction unclear: 1
- reducing inflammation · Distinct papers needing additional review: 1Evidence criteria check: 1
One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.
Representative outcome and study details
Studies with an unspecified organism reported a change with no confirmed comparison group in anti-inflammatory.
Scope not specified · comparator not confirmed
1 publications linked to this result
- Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: C
The 21.6 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 90
Papers linked to this topic 4 · distinct papers 4 · comparison findings need further review · papers needing additional review 3
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
- anti-inflammatory: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- expression of inflammatory cytokines IL-6, TNF-α and IL-1β: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- proliferation of lymphocytes: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
- reducing inflammation: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
What the research found
anti-inflammatory
A change was reported, but the comparison could not be confirmed.
Review · Unknown intervention · General population
Analysis coverage and paper counts
1 paper · 1 measured outcome
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
expression of inflammatory cytokines IL-6, TNF-α and IL-1β
The study needs further checking before its result can be interpreted.
Cell study · indirect · Separable contribution · General population
This finding comes from animal or cell research. It does not establish the same effect in people.
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
proliferation of lymphocytes
The study needs further checking before its result can be interpreted.
Cell study · indirect · Separable contribution · General population
This finding comes from animal or cell research. It does not establish the same effect in people.
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
reducing inflammation
The study needs further checking before its result can be interpreted.
Review · Single ingredient · Unspecified population
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Review overlap with primary papers is unknown; counts stay separate.
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
Unspecified measured outcome
The study needs further checking before its result can be interpreted.
Other evidence · Single ingredient · Patient group
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
How to read research findings
How should I read research findings?
Research guidesNo clear difference and an uninterpretable result are different
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Paper counts and study counts are different
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Side effects and combination findings
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No reviewed caution rules are available yet. Reported caution findings are shown below.
Findings to review with care
Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.
Side effects reported with this ingredient alone
Symptoms or adverse events reported in studies without another active ingredient.
gastrointestinal disturbance1 papers
Hericium erinaceus is well tolerated, with gastrointestinal disturbance being the most common adverse effect.Human studies · Systematic reviewGastrointestinal discomfort, headache, allergic reactions1 papers
Review notes potential side effects of Hericium erinaceus include stomach discomfort, headache, and allergic reactions, though commonly unreported.Human studies · Systematic review